Sintx Technologies Inc (SINT) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Sintx Technologies Inc   (NASDAQ: SINT)
 

Sintx Technologies Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Sintx Technologies Inc 's inventory turnover ratio sequentially decreased to 0.51 in the second quarter 2026, unsurprisingly, as the Sintx Technologies Inc markets continue to deteriorate, and SINT's faces growing challenges to bring down its inventories. Sintx Technologies Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 716 days, from 507 days, in the Mar 31 2026 quarter.

Within Healthcare sector 353 other companies have achieved higher inventory turnover ratio. While inventory turnover ranking remained unchanged in the Second Quarter 2026 compared to previous quarter at no. 1502.

SINT Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Sintx Technologies Inc Market Share?

What is Inventory Turnover Ratio?




SINT Inventory Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 534.37 % 228 % 64.34 % -3.46 % -20.22 %
Y / Y Cost of Sales Growth 85.11 % -4.07 % -33.77 % -45.24 % -58.04 %
Inventory Turnover Ratio (TTM) 0.51 0.72 1.09 1.41 1.61
SINT's Total Ranking # 1502 # 1502 # 1467 # 1510 # 1339
Average inventory processing period 716 504 336 259 226
Seq. Inventory Growth 61.55 % 68.97 % 84.56 % 25.92 % -16.47 %
Seq. Cost of Sales Growth -26.27 % 131.37 % -11.3 % 22.34 % -61.79 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 156
Healthcare Sector # 354
Overall Market # 1502

Inventory Turnover Ratio Statistics
High Average Low
4.99 1.62 0.31
(Jun 30 2020)   (Jun 30 2019)




Financial Statements
Sintx Technologies Inc 's Inventories $ 2 Millions Visit SINT's Balance sheet
Sintx Technologies Inc 's Cost of Revenues TTM $ 1 Millions Visit SINT's Income Statement
What are SINT's Sales? Visit SINT's Sales by Segment

Other Inventory Turnover Ratios
Sintx Technologies Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
SINT's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for SINT's Competitors
Inventory Turnover Ratio for SINT's Suppliers
Inventory Turnover Ratio for SINT's Customers

You may also want to know
SINT's Sales Growth Rates SINT's Pe Price to earnings ratio SINT's Receivables Turnover Ratio SINT's Stock Quote
SINT's Net Income Growth Rates SINT's Ps Price to Sales ratio SINT's Sales per Employee SINT's Asset Turnover Ratio
SINT's Net Margin SINT's Pb Price to Book ratio SINT's Financial Strength Ratios SINT's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Sensus Healthcare Inc   0.76 $ 11.924  Millions$ 16  Millions
Nuvation Bio Inc   0.76 $ 10.000  Millions$ 13  Millions
Lexicon Pharmaceuticals Inc   0.75 $ 0.358  Millions$ 0  Millions
Picard Medical Inc   0.71 $ 4.811  Millions$ 7  Millions
Immunocore Holdings Plc  0.67 $ 4.738  Millions$ 7  Millions
Gyre Therapeutics Inc   0.65 $ 6.807  Millions$ 10  Millions
Liquidia Corporation  0.64 $ 18.181  Millions$ 28  Millions
Bioxcel Therapeutics Inc   0.64 $ 0.348  Millions$ 1  Millions
Envoy Medical Inc   0.64 $ 1.005  Millions$ 2  Millions
X4 Pharmaceuticals Inc  0.63 $ 2.930  Millions$ 5  Millions
Organogenesis Holdings Inc   0.62 $ 19.764  Millions$ 32  Millions
Xeris Biopharma Holdings Inc   0.62 $ 45.029  Millions$ 73  Millions
Lenz Therapeutics Inc   0.62 $ 1.774  Millions$ 3  Millions
Jaguar Health Inc   0.57 $ 4.921  Millions$ 9  Millions
Travere Therapeutics Inc   0.57 $ 8.263  Millions$ 14  Millions
Cvrx inc   0.57 $ 6.981  Millions$ 12  Millions
Biomarin Pharmaceutical Inc  0.57 $ 813.588  Millions$ 1,434  Millions
Verastem Inc   0.54 $ 1.128  Millions$ 2  Millions
Ionis Pharmaceuticals Inc   0.53 $ 9.873  Millions$ 19  Millions
Heron Therapeutics Inc   0.53 $ 45.572  Millions$ 86  Millions
Orchestra Biomed Holdings Inc   0.52 $ 0.157  Millions$ 0  Millions
Sintx Technologies Inc   0.51 $ 0.627  Millions$ 1  Millions
Siga Technologies Inc  0.50 $ 24.494  Millions$ 49  Millions
Ardelyx inc   0.50 $ 25.401  Millions$ 51  Millions
Regeneron Pharmaceuticals Inc   0.49 $ 1,549.600  Millions$ 3,161  Millions
Orthopediatrics Corp  0.49 $ 65.142  Millions$ 134  Millions
Scienture Holdings Inc   0.47 $ 0.101  Millions$ 0  Millions
Co diagnostics Inc   0.44 $ 0.412  Millions$ 1  Millions
Immunitybio inc   0.43 $ 1.095  Millions$ 3  Millions
Pelthos Therapeutics Inc   0.40 $ 9.271  Millions$ 23  Millions

Date modified: 2026-10-05T11:03:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.